Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders
Amr Ali Mohamed Abdelgawwad El‐SehrawyInternal Medicine, Diabetes, Endocrinology and Metabolism, Mansoura University, Mansoura, Egypt. Electronic address: [email protected]Ghaleb OriquatFaculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, JordanSokhib SaidovDepartment of Neurosurgery, Samarkand State Medical University, Samarkand, UzbekistanUktam RuzikulovDepartment of Traumatology, Orthopedics, and Neurosurgery, Tashkent State Medical University. Tashkent, UzbekistanGulnora ShakhmurovaDepartment of Biological Sciences, National Pedagogical University of Uzbekistan named after Nizami, Tashkent, UzbekistanBnyn Jasb JblDepartment of Tqnyat Almkhtbrat Altbyh, College Altqnyat Altbyh, The Islamic University, Najaf, IraqDivya SinghalCentre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India; Sharda School of Bio-Science & Technology, Sharda University, Greater Noida, IndiaShefaliUniversity Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 206